Birchbrook’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Sell
4,265
-1,256
-23% -$112K 0.21% 62
2026
Q1
$396K Sell
5,521
-144
-3% -$11.1K 0.19% 59
2025
Q4
$450K Sell
5,665
-369
-6% -$29.1K 0.22% 56
2025
Q3
$455K Buy
6,034
+239
+4% +$16.4K 0.24% 55
2025
Q2
$400K Buy
5,795
+288
+5% +$18.9K 0.21% 56
2025
Q1
$373K Sell
5,507
-713
-11% -$42.7K 0.21% 55
2024
Q4
$279K Sell
6,220
-4,019
-39% -$225K 0.16% 55
2024
Q3
$644K Buy
10,239
+146
+1% +$8.52K 0.36% 46
2024
Q2
$596K Sell
10,093
-2
-0% -$125 0.36% 46
2024
Q1
$805K Sell
10,095
-578
-5% -$44.2K 0.48% 41
2023
Q4
$843K Buy
+10,673
New +$760K 0.56% 40

Other funds holding CVS

Birchbrook's CVS Position: Q2 2026 in Review

Birchbrook reduced its CVS Health (CVS) stake by 23% in Q2 2026, selling an estimated $112K and leaving 4,265 shares worth $441K. The position accounts for 0.21% of the portfolio, ranked #62.

Birchbrook first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $843K in Q4 2023. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Birchbrook held 4,265 shares of CVS Health worth $441K as of Q2 2026.
  • Birchbrook sold 1,256 CVS Health shares in Q2 2026, an estimated $112K.
  • CVS Health made up 0.21% of Birchbrook's portfolio in Q2 2026, its #62 holding.
  • Birchbrook first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's CVS Health position peaked at $843K in Q4 2023.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.